IBDEI1GF ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24705,2)
 ;;=^5063138
 ;;^UTILITY(U,$J,358.3,24706,0)
 ;;=G21.19^^93^1101^11
 ;;^UTILITY(U,$J,358.3,24706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24706,1,3,0)
 ;;=3^Medication-Induced Parkinsonism NEC
 ;;^UTILITY(U,$J,358.3,24706,1,4,0)
 ;;=4^G21.19
 ;;^UTILITY(U,$J,358.3,24706,2)
 ;;=^5003773
 ;;^UTILITY(U,$J,358.3,24707,0)
 ;;=G21.11^^93^1101^14
 ;;^UTILITY(U,$J,358.3,24707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24707,1,3,0)
 ;;=3^Neuroleptic-Induced Parkinsonism
 ;;^UTILITY(U,$J,358.3,24707,1,4,0)
 ;;=4^G21.11
 ;;^UTILITY(U,$J,358.3,24707,2)
 ;;=^5003772
 ;;^UTILITY(U,$J,358.3,24708,0)
 ;;=G24.02^^93^1101^8
 ;;^UTILITY(U,$J,358.3,24708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24708,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,24708,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,24708,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,24709,0)
 ;;=G24.01^^93^1101^16
 ;;^UTILITY(U,$J,358.3,24709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24709,1,3,0)
 ;;=3^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,24709,1,4,0)
 ;;=4^G24.01
 ;;^UTILITY(U,$J,358.3,24709,2)
 ;;=^5003784
 ;;^UTILITY(U,$J,358.3,24710,0)
 ;;=G24.09^^93^1101^17
 ;;^UTILITY(U,$J,358.3,24710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24710,1,3,0)
 ;;=3^Tardive Dystonia
 ;;^UTILITY(U,$J,358.3,24710,1,4,0)
 ;;=4^G24.09
 ;;^UTILITY(U,$J,358.3,24710,2)
 ;;=^5003786
 ;;^UTILITY(U,$J,358.3,24711,0)
 ;;=G25.1^^93^1101^12
 ;;^UTILITY(U,$J,358.3,24711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24711,1,3,0)
 ;;=3^Medication-Induced Postural Tremor
 ;;^UTILITY(U,$J,358.3,24711,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,24711,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,24712,0)
 ;;=G25.71^^93^1101^15
 ;;^UTILITY(U,$J,358.3,24712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24712,1,3,0)
 ;;=3^Tardive Akathisia/Medication-Induced Acute Akatisia
 ;;^UTILITY(U,$J,358.3,24712,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,24712,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,24713,0)
 ;;=G25.79^^93^1101^10
 ;;^UTILITY(U,$J,358.3,24713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24713,1,3,0)
 ;;=3^Medication-Induced Movement Disorder NEC
 ;;^UTILITY(U,$J,358.3,24713,1,4,0)
 ;;=4^G25.79
 ;;^UTILITY(U,$J,358.3,24713,2)
 ;;=^5003800
 ;;^UTILITY(U,$J,358.3,24714,0)
 ;;=T43.205A^^93^1101^4
 ;;^UTILITY(U,$J,358.3,24714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24714,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
 ;;^UTILITY(U,$J,358.3,24714,1,4,0)
 ;;=4^T43.205A
 ;;^UTILITY(U,$J,358.3,24714,2)
 ;;=^5050540
 ;;^UTILITY(U,$J,358.3,24715,0)
 ;;=T43.205D^^93^1101^5
 ;;^UTILITY(U,$J,358.3,24715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24715,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,24715,1,4,0)
 ;;=4^T43.205D
 ;;^UTILITY(U,$J,358.3,24715,2)
 ;;=^5050541
 ;;^UTILITY(U,$J,358.3,24716,0)
 ;;=T43.205S^^93^1101^6
 ;;^UTILITY(U,$J,358.3,24716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24716,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
 ;;^UTILITY(U,$J,358.3,24716,1,4,0)
 ;;=4^T43.205S
 ;;^UTILITY(U,$J,358.3,24716,2)
 ;;=^5050542
 ;;^UTILITY(U,$J,358.3,24717,0)
 ;;=G25.71^^93^1101^7
 ;;^UTILITY(U,$J,358.3,24717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24717,1,3,0)
 ;;=3^Medication-Induced Acute Akathisia
 ;;^UTILITY(U,$J,358.3,24717,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,24717,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,24718,0)
 ;;=G24.02^^93^1101^9
 ;;^UTILITY(U,$J,358.3,24718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24718,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
